Virology, Immunology, Antigen, Mycobacterium tuberculosis and Immune system are his primary areas of study. His Virology research integrates issues from Leishmaniasis Vaccines, Leishmania major, Leishmania, Recombinant DNA and Epitope. His Immunology research focuses on Adjuvant, Leishmaniasis, Cytokine, Vaccination and Immunotherapy.
His Adjuvant research is multidisciplinary, relying on both Agonist, Monophosphoryl Lipid A, Lipid A and Pharmacology. His work focuses on many connections between Antigen and other disciplines, such as Interferon gamma, that overlap with his field of interest in Interleukin 4. Steven G. Reed has researched Mycobacterium tuberculosis in several fields, including T cell and Mycobacterium.
Steven G. Reed spends much of his time researching Immunology, Virology, Antigen, Adjuvant and Immune system. Steven G. Reed frequently studies issues relating to Tuberculosis vaccines and Immunology. His Virology study combines topics from a wide range of disciplines, such as Recombinant DNA, Leishmaniasis, Tuberculosis, Mycobacterium tuberculosis and Epitope.
His Recombinant DNA research is multidisciplinary, incorporating perspectives in Molecular biology and Molecular cloning. His studies examine the connections between Antigen and genetics, as well as such issues in Antibody, with regards to Chagas disease. He studied Adjuvant and Immunogenicity that intersect with Leishmaniasis Vaccines.
His scientific interests lie mostly in Immunology, Virology, Immune system, Adjuvant and Antigen. His Immunology study integrates concerns from other disciplines, such as Tuberculosis and Mycobacterium tuberculosis. His Mycobacterium tuberculosis research incorporates elements of BCG vaccine and Virulence.
Steven G. Reed has included themes like Recombinant DNA, Leishmaniasis and Epitope, Antibody, Immunogenicity in his Virology study. He interconnects Cytokine, Agonist, Monophosphoryl Lipid A, TLR4 and Cytotoxic T cell in the investigation of issues within Adjuvant. His Antigen study also includes
Steven G. Reed focuses on Immunology, Immune system, Virology, Adjuvant and Antibody. The various areas that Steven G. Reed examines in his Immunology study include Tuberculosis vaccines, Tuberculosis and Leishmania. His work carried out in the field of Immune system brings together such families of science as Replicon, Leishmaniasis and Tuberculoid leprosy, Lepromatous leprosy.
The concepts of his Virology study are interwoven with issues in Epitope, Immunogen, Immunization and Immunogenicity. His work is dedicated to discovering how Adjuvant, Agonist are connected with TLR7, Combinatorial chemistry and Ligand and other disciplines. His Antibody study frequently draws connections between related disciplines such as Recombinant DNA.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.
Patricia A Darrah;Dipti T Patel;Paula M De Luca;Ross W B Lindsay.
Nature Medicine (2007)
Key roles of adjuvants in modern vaccines
Steven G Reed;Mark T Orr;Christopher B Fox.
Nature Medicine (2013)
New horizons in adjuvants for vaccine development
Steven G. Reed;Sylvie Bertholet;Rhea N. Coler;Martin Friede.
Trends in Immunology (2009)
Identification of differentially expressed genes in human prostate cancer using subtraction and microarray.
Jiangchun Xu;John A. Stolk;Xinqun Zhang;Sandra J. Silva.
Cancer Research (2000)
P504S: a new molecular marker for the detection of prostate carcinoma.
Zhong Jiang;Bruce A. Woda;Kenneth L. Rock;Yingdan Xu.
The American Journal of Surgical Pathology (2001)
Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism
Manoel Barral-Netto;Aldina Maria Prado Barral;Cari E. Brownell;Yasir A. W. Skeiky.
Science (1992)
CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania major
Kim A Campbell;Pamela J Ovendale;Mary K Kennedy;William C Fanslow.
Immunity (1996)
Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein.
Yasir A. W. Skeiky;Mark R. Alderson;Pamela J. Ovendale;Jeffrey A. Guderian.
Journal of Immunology (2004)
Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.
Edgar M. Carvalho;Roberto Badaro;Steven G. Reed;Thomas C. Jones.
Journal of Clinical Investigation (1985)
Use of defined TLR ligands as adjuvants within human vaccines.
Malcolm S. Duthie;Hillarie Plessner Windish;Christopher B. Fox;Steven G. Reed.
Immunological Reviews (2011)
Infectious Disease Research Institute
Federal University of Bahia
Program for Appropriate Technology in Health
Colorado State University
Duke University
Duke University
Corixa Corporation
National Institutes of Health
Duke University
Duke University
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: